Article
MGMT promoter gene methylation and neurological scale improvement in glioma: a cohort study
2021-03-30
Abstract excerpt
<h4>Background: </h4> : Glioma is one of the most common primary brain tumours and conveys a dismal prognosis despite aggressive treatment. Several biomarkers have been studied in the hope of yielding better diagnostic accuracy and improving patient management. Besides survival, functional and neurological disability are concerns that have no lesser importance. In 2017, a disease-specific assessment tool – the Neu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- eb814c2d-d6b5-5586-a4f8-cf5ecebf4b54
- DOI
- 10.12688/f1000research.51213.2
